Description: As results emerged showing the influence of COVID-19 on recent mortality, the Society of Actuaries Research Institute’s Mortality and Longevity Strategic Research Program Steering Committee (MLPSC) began to ponder what it means for the future. Was the coronavirus pandemic just a temporary shock to U.S. mortality with mortality quickly returning to prepandemic levels upon its conclusion or a lingering factor in future U.S. mortality from the potential occurrence of new coronavirus variants, post-COVID-19 conditions (“long COVID”), deferral of needed health care treatment, a fatigued health care system and other elements? Only time will provide the answers to these questions.

Description: The purpose of this status report is to advise practitioners about subsequent research and analysis conducted by the Advisory Group regarding these items. At this time, there are no new enhancements to the MIM-2021 tools.

Description: LIMRA, Reinsurance Group of America (RGA), the Society of Actuaries (SOA), and TAI have collaborated on an ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. The Individual Life COVID-19 Project Work Group (Work Group) was formed as a collaboration of LIMRA, RGA, the SOA, and TAI to design, implement, and create the study and to produce and distribute a variety of analyses. This report is the fifth public release from this collaboration and contains the results of a cause of death analysis focused on how the rates of death for various causes were impacted throughout the pandemic period through the first quarter of 2021.

Description: View the Social and Other Determinants of Life Insurance Demand

Description: This report models and forecasts future mortality improvements in China, by geographical regions, as well as by causes of death. Deaths and population exposures data provided by the Chinese Center for Disease Control and Prevention was used for the period 2004–2019.

Description: An ongoing effort to analyze the impact of COVID-19 on the individual life insurance industry’s mortality experience and share the emerging results with the insurance industry and the public. This report documents a high-level analysis of the claims that have been reported through September 30, 2021.

Description: In the third quarter of 2022, publicly traded life insurers reported on their financial and operational activities, which included a downturn in income from alternative investments, the continuing impact of COVID, the impact of equity market returns on variable annuity products, and growth trends related to pension risk transfer transactions.

Description: Addendum to 2022 Cause of Death Report.

Description: In this report, we consider high-level results from provisional mortality data released from the U.S. Centers for Disease Control and Prevention (CDC) for 2021, including looking at changes by sex and age group.

Description: 2023 Generally Recognized Expense Table (GRET) recommendations.